Ticker symbol “CLOV” S&P 500 Aspirations or Investor Fantasy?

1. Clover becomes a healthcare software company, not just an insurer. 2. When (Counterpart) Clover AI is the first thing doctors think about in the morning, CLOV belongs in the S&P 500. Share of mind → market share. 3. Clover AI (Counterpart Health) isn’t admin software, it’s clinical decision intelligence. It helps doctors decide what to do at the point of care, improving outcomes directly. The moat is proprietary clinical data that gets smarter over time. 4. Clover Health has crossed into profitability while still growing fast, which is rare in Medicare Advantage. Hats off to Vivek and the team 🙏. 5. Insiders collectively own \\\~21% of the company. This level of insider stake is relatively high and is generally seen as aligning management’s incentives with shareholders. The biggest insider buy was by Co-Founder & Executive Chairman Vivek Garipalli, who purchased approximatelyy $1M in shares at \\\~$2.24 each. Market Confidence is back.